Please try another search
Sakar Healthcare Limited research, develops, manufactures, and markets pharmaceutical products in India. It provides liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. The company’s product portfolio consists of formulations in approximately 22 therapeutic areas, such as antacid, antimalerial, anticoagulant, laxative, anthelmintic, bronchodilator, anaesthetic, antidepressant, sedative, adrenergic, anti-infective, diuretics, oxytocic, analgesic, antiemetic, antipsychotic, antifungal, PPI, anticonvulsant, anti-inflammatory, antihistamine, and multi vitamins. It also exports its products to approximately 38 countries, including Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. The company was incorporated in 2004 and is based in Ahmedabad, India.
Name | Age | Since | Title |
---|---|---|---|
Aarsh Sanjay Shah | 30 | 2012 | Joint MD & Executive Director |
Hemendrakumar Chamanlal Shah | 69 | 2020 | Independent Director |
Sanjay Surendra Shah | 62 | 2004 | Chairman & MD |
Ritaben Sanjay Shah | 57 | 2004 | Whole-Time Director |
Prashant Chandraprakash Srivastav | 43 | 2015 | Independent Non-Executive Director |
Shailesh Bhanubhai Patel | 61 | 2015 | Non-Executive Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review